Your Trusted Partner in Regenerative Medicine

Making Cells Work Better

Tomorrow's Technology for Today's Challenges

LIVECYTE AMNIOTIC TISSUE FLOWABLE SUSPENSION

Our revolutionary LiveCyte-TX products can be used intraoperatively or through injection therapies to integrate with injured tissue.

LIVECYTE AMNIOTIC FLUID

Cytes obtained from the amniotic fluid have recently become an interesting alternate source of pluripotent cytes for therapeutic applications.

R

HUMAN UMBILICAL CORD CYTES

Umbilical cord blood is a rich source of hematopoietic stem cells that are
similar to those found in the bone
marrow.

Pioneering in Regenerative Medicine.

Regenerative Medicine Treats Various Medical Conditions
  •   Orthopedics
  •   Treatment of Arthritis
  •   Treatment of Heart Disease
  •  Treatment of Autoimmune Disorders

10+

Years of Experience

180+

Healed People

13+

Doctors and Staff

1120+

Vials Delivered

Featured Products

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

LiveCyte-UCB

Umbilical Cord Blood Stem Sell Suspension

Umbilical cord blood is a rich source of hematopoietic cytes that are similar to those found in the bone marrow and have the ability to develop into all the different blood cell types creating the blood and immune system. Hematopoietic stem cells are used for transplantation to reconstitute the blood and immune system in numerous malignant and non-malignant conditions like Leukemias, Fanconi anemia, Sickle cell disease, Thalassemia, Wiskott-Aldrich syndrome, Chronic granulomatous disease to name a few.

Research & Development

Medical Team

R

Online Orders

24/7 Support

p

Request More Information

Feel free to bring a friend or family member to potentially stressful visits.

Frequently Asked Questions

Expectant parents can –
• collect and preserve for the potential medicinal benefit of the family.
• donate the blood for research or use by a third party. This is commonly referred to as the public option.
• allow the hospital to discard it.
Cord blood and cord tissue have an abundance of stem cells that can easily be collected and cryopreserved in case they are ever needed. Stem cell treatments and transplants have already been used for a wide range of diseases and conditions such as cancers (including lymphoma and leukemia) and inherited metabolic disorders. In addition, research for future uses of stem cells in the treatment of diabetes, Alzheimer’s, autism and cerebral palsy holds great promise.
Approximately nine of every 10 cord blood samples donated to a public bank are discarded. If your baby needs a stem cell transplant, finding a match through public cord blood banks is not a guarantee, and odds are even lower for certain ethnicities. The retrieval process and necessary testing to ensure candidates are a proper match can take valuable weeks, even months, to perform. Retrieving a match from a public bank is also expensive. The current average cost is $40,000 for retrieval from a public cord blood unit.
Cord blood stem cells have a number of significant advantages over other sources of stem cells (e.g., bone marrow):
• Higher rate of engraftment
• More tolerant of tissue mismatches
• Lower rate of severe graft-vs.-host disease (a major complication in stem cell transplants)
• Less likely to be contaminated with latent viruses
• Easier to collect in some cases
In addition, cord blood is “privileged,” or unexposed to most diseases, which can make bone marrow from an adult more difficult to use in transplantation. Most importantly, cord blood from your baby is a perfect match for your child, in the unlikely event it should ever be needed, and has a 75 percent chance of being an acceptable match for any siblings. It is important to note that a perfect match may not imply that the cells would be useful to treat certain diseases of the donor.
Umbilical cord blood was first used for transplantation in France in 1988 for a patient with Fanconi’s anemia; a disease-free sibling was the donor. Since that time, cord blood has become a standard alternative to bone marrow and has been used in more than 35,000 successful transplants (33% of which were for patients age 18 or younger).
Fill out my online form